Print Save or Share

Lamivudine

In the US, Lamivudine (lamivudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B, HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF05

CAS registry number (Chemical Abstracts Service)

0134678-17-4

Chemical Formula

C8-H11-N3-O3-S

Molecular Weight

229

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of hepatitis B

Chemical Names

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (WHO)

(-)-4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxythiolan-5-yl]pyrimidin-2(1H)-one (Ph. Int.)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-

Foreign Names

Lamivudinum (Latin)
Lamivudin (German)
Lamivudine (French)
Lamivudina (Spanish)

Generic Names

Lamivudine (OS: USAN, DCF, BAN)
3-TC (IS)
GR 109714 X (IS: Glaxo)
Lamivudine (PH: BP 2011, Ph. Eur. 7, Ph. Int. 4, USP 34)
Lamivudinum (PH: Ph. Eur. 7, Ph. Int. 4)

Brand Names

3TC COMPLEX (Lamivudine and Zidovudine)
GlaxoSmithKline, Argentina
3-TC/AZT ELEA (Lamivudine and Zidovudine)
Elea, Argentina
3TC
GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, South Korea; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Switzerland
3TC-HBV
GlaxoSmithKline, Indonesia
Adco-Lamivudine
Adcock Ingram Pharmaceuticals, South Africa
Amilitrap
Dosa, Argentina
Antiheb
Mebiphar, Vietnam
Aspen Lamivudine
Aspen Pharmacare, South Africa
Aspen Lamzid (Lamivudine and Zidovudine)
Aspen Pharmacare, South Africa
Avilam
Beximco, Bangladesh
Avocomb (Lamivudine and Zidovudine)
Ranbaxy Laboratories, Ethiopia
Avolam
Ranbaxy Laboratories, Ethiopia
Avudin (Lamivudine and Zidovudine)
Square, Bangladesh
Biovir (Lamivudine and Zidovudine)
GlaxoSmithKline, Brazil
Cipla-Duovir (Lamivudine and Zidovudine)
Cipla Medpro, South Africa
Cipla-Lamivudine
Cipla Medpro, South Africa
Combid (Lamivudine and Zidovudine)
GlaxoSmithKline, Thailand
Combivir (Lamivudine and Zidovudine)
Glaxo, Latvia; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, United States; ViiV Healthcare ULC, Canada; Viivhiv, Portugal; Wellcome, Bosnia & Herzegowina
Coviro (Lamivudine and Stavudine)
Ranbaxy, Myanmar
Cytocom (Lamivudine and Zidovudine)
Alkem, India
Cytocom-N (Lamivudine and Zidovudine, + Nevirapine)
Alkem, India
Diavix (Lamivudine and Zidovudine)
Beximco, Bangladesh
Duovir (Lamivudine and Zidovudine)
Cipla, Ethiopia; Cipla, India
Duovir-N (Lamivudine and Zidovudine, + Nevirapine)
Cipla, India
Duovox (Lamivudine and Zidovudin)
Biotoscana, Peru
Emduo (Lamivudine and Stavudine)
Emcure, India; Emcure, Myanmar
Emduo-JR (Lamivudine and Stavudine (pediatric))
Emcure, India
Emduo-N (Lamivudine and Stavudine, + Nevirapine)
Emcure, India
Emtri (Lamivudine and Stavudine, + Nevirapine)
Emcure, India; Emcure, Myanmar
Emtri JR (Lamivudine and Stavudine, + Nevirapine (pediatric))
Emcure, India
Epivir 3TC
GlaxoSmithKline, Chile; GlaxoSmithKline, Russian Federation
Epivir
Glaxo, Latvia; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Belgium; GlaxoSmithKline, Brazil; GlaxoSmithKline, China; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Peru; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela; ViiV, Austria; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, United States
Epivir-HBV
GlaxoSmithKline, United States
Epzicom (Lamivudine and Abacavir)
GlaxoSmithKline, Japan; ViiV Healthcare, United States
Flamivud
Flamingo Pharmacueticals, Ethiopia
Ganvirel
Ivax, Argentina
Ganvirel Duo (Lamivudine and Zidovudine)
Ivax, Argentina
Gpo-Vir (Lamivudine and Nevirapine, + Stavudine)
GPO, Thailand
Hepavir
Square, Bangladesh
Hepitec
GlaxoSmithKline, India
Heptavir
Hetero, Georgia
Heptodin
GlaxoSmithKline, China
Heptodine
GlaxoSmithKline, Argentina
Heptovir
GlaxoSmithKline, Canada
Imunoxa
Gador, Argentina
Inhavir
Biogen, Colombia
Kess
Filaxis, Argentina
Kivexa (Lamivudine and Abacavir)
Glaxo Group, Poland; Glaxo Group, Slovenia; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Chile; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
Ladiwin
Cadila Health Care, Ethiopia
Lamda
Cadila, India
Lamda-Z (Lamivudine and Zidovudine)
Cadila, India
Lamibergen
Paylos, Argentina
Lamidac
Cadila Health Care, Ethiopia; Zydus, India; Zydus Cadila, Myanmar
Lamidin
Eskayef, Bangladesh; Medibios Laboratories, Ethiopia
Lamidine
Synmosa, Taiwan
Lamilea
Elea, Argentina
Lamimac
Macleods Pharmaceuticals, Ethiopia
Lamitec
Zifam India, Myanmar
Lamitec-S (Lamivudine and Stavudine)
Zifam India, Myanmar
Lamivir
Cipla, Georgia; Cipla, India; Flamingo Pharmacueticals, Ethiopia; GPO, Thailand; Incepta, Bangladesh; Pharmaceutical, Venezuela
Lamivir-S (Lamivudine and Stavudine)
Cipla, India
Lamivox
Aurobindo, Ethiopia; Biotoscana, Peru
Lamivudin Hasan
Hasan, Vietnam
Lamivudin Stada
Stada-VN JV, Vietnam
Lamivudina Delta
Delta Farma, Argentina
Lamivudina Microsules
Microsules, Argentina
Lamivudina
Biocrom, Peru; Induquimica, Peru
Lamivudine and Zidovudine Aurobindo (Lamivudine and Zidovudine)
Aurobindo, United States
Lamivudine and Zidovudine Lupin (Lamivudine and Zidovudine)
Lupin, United States
Lamivudine and Zidovudine Teva (Lamivudine and Zidovudine)
Teva, United States
Lamivudine Apotex
Apotex, United States
Lamivudine Aurobindo
Aurobindo, United States
Lamivudine Teva Pharma B.V.
Teva, Latvia
Lamivudine Teva
Teva, Lithuania; Teva, Latvia
Lamivudin-Teva
Teva Pharma, Switzerland
Lamivur
Cipla, Ethiopia
Lamiwudyna/Zydowudyna Mylan (Lamivudine and Zidovudine)
Mylan, Poland
Lamostad (Lamivudine and Stavudine)
Alkem, India
Lamostad-N (Lamivudine and Nevirapine, + Stavudine)
Alkem, India
Lamuzid (Lamivudine and Zidovudine)
Cadila Health Care, Ethiopia; Zydus, India; Zydus Cadila, Myanmar
Lamzidivir (Lamivudine and Zidovudine)
Stada-VN JV, Vietnam
Lamzitrio (Lamivudine and Zidovudine, + Nevirapine)
Stada-VN JV, Vietnam
Lasovir (Lamivudine and Zidovudine)
Zifam India, Myanmar
Lavir
Emcure, India; Emcure, Myanmar
Laviz
DHG Pharma, Vietnam
Lazid (Lamivudine and Stavudine)
Emcure, Myanmar
Lazid (Lamivudine and Zidovudine)
Emcure, India
Lazid-N (Lamivudine and Zidovudine, + Nevirapine)
Emcure, India
Lazivir (Lamivudine and Zidovudine)
Celon, Poland
Maxivir (Lamivudine and Stavudine, + Nevirapine)
Okasa, Myanmar
Medilam (Lamivudine and Stavudine)
Meditab, Myanmar
Medivir (Lamivudine and Zidovudine)
Meditab, Myanmar
Medovir
Sanovel, Turkey
Mivux
Nobel, Turkey
Nevitrio (Lamivudine and Nevirapine, + Stavudine)
Stada-VN JV, Vietnam
Oralmuv
LKM, Argentina
Pilafix
PMP, Vietnam
Retrolam
Alkem, India
Shanvudin
Shantha, India
Sonke-LamiNevStav (Lamivudine and Nevirapine, + Stavudine)
Ranbaxy, South Africa
Sonke-Lamivudine + Zidovudine (Lamivudine and Zidovudine)
Ranbaxy, South Africa
Sonke-Lamivudine
Ranbaxy, South Africa
Sonke-Lastad (Lamivudine and Stavudine)
Ranbaxy, South Africa
Stavex (Lamivudine and Stavudine, + Nevirapine)
Aurobindo, India
Tivizid (Lamivudine and Zidovudine + Abacavir)
Square, Bangladesh
Triomune (Lamivudine and Stavudine, + Nevirapine)
Cipla Medpro, South Africa
Triovix (Lamivudine and Zidovudine + Nevirapine)
Beximco, Bangladesh
Trizivir (Lamivudine and Abacavir, + Zidovudine)
Glaxo Group, Austria; Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; Novo Nordisk, Denmark; Shire, Canada; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, United States; Viivhiv, Portugal
Trovir (Lamivudine and Zidovudine, + Nevirapine)
Zifam India, Myanmar
Victron
ICA Pharmaceuticals, Vietnam
Vifix
PMP, Vietnam
Viradin
Healthcare, Bangladesh
Viramid
Lupin, India
Virdual (Lamivudine and Zidovudine)
Biogen, Colombia
Virocomb (Lamivudine and Zidovudine)
Ranbaxy, India; Ranbaxy, Myanmar
Virocomb-N (Lamivudine and Nevirapine, + Zidovudine)
Ranbaxy, India; Ranbaxy, Myanmar
Virolam
Ranbaxy, India
Virolans (Lamivudine and Nevirapine, + Stavudine)
Ranbaxy, India; Ranbaxy, Myanmar
Virolis (Lamivudine and Stavudine)
Ranbaxy, India
Virozen (Lamivudine and Stavudine, + Nevirapine)
Zifam India, Myanmar
Vuclodir
Richmond, Argentina
Vudirax
Blausiegel, Brazil
Zeffix
Glaxo, Latvia; Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Group Limited-GB, Italy; Glaxo Wellcome, Serbia; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, South Korea; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan
Zefix
GlaxoSmithKline, Japan
Zefomen
Mustafa Nevzat, Turkey

International Drug Name Search

Glossary

Term	Definition
BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Ph. Int.	Pharmacopoea Internationalis
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.